Compare MNTK & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNTK | PROF |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.9M | 199.3M |
| IPO Year | 2021 | N/A |
| Metric | MNTK | PROF |
|---|---|---|
| Price | $1.72 | $6.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.33 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 179.0K | 101.4K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $160,682,000.00 | $14,297,000.00 |
| Revenue This Year | $2.45 | $64.23 |
| Revenue Next Year | $15.31 | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $1.56 | $3.76 |
| 52 Week High | $4.96 | $8.36 |
| Indicator | MNTK | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 57.49 |
| Support Level | $1.58 | $6.09 |
| Resistance Level | $1.80 | $7.04 |
| Average True Range (ATR) | 0.13 | 0.42 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 50.70 | 70.27 |
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.